TILRAY INC

NASDAQ: TLRY (Tilray Brands, Inc.)

Kemas kini terakhir: 13 Nov, 4:42AM

1.23

-0.06 (-4.65%)

Penutupan Terdahulu 1.29
Buka 1.28
Jumlah Dagangan 33,837,779
Purata Dagangan (3B) 75,157,466
Modal Pasaran 1,381,121,664
Harga / Jualan (P/S) 0.920
Harga / Buku (P/B) 0.610
Julat 52 Minggu
0.350 (-71%) — 2.32 (88%)
Tarikh Pendapatan 8 Jan 2026
Margin Keuntungan -114.40%
Margin Operasi (TTM) -16.76%
EPS Cair (TTM) -1.10
Pertumbuhan Hasil Suku Tahunan (YOY) -1.40%
Jumlah Hutang/Ekuiti (D/E MRQ) 12.73%
Nisbah Semasa (MRQ) 2.62
Aliran Tunai Operasi (OCF TTM) -51.09 M
Aliran Tunai Bebas Leveraj (LFCF TTM) 26.37 M
Pulangan Atas Aset (ROA TTM) -1.63%
Pulangan Atas Ekuiti (ROE TTM) -30.73%

Arah Aliran Pasaran

Jangka Pendek Jangka Sederhana
Industri Drug Manufacturers - Specialty & Generic (US) Menaik Bercampur
Drug Manufacturers - Specialty & Generic (Global) Menaik Bercampur
Stok Tilray Brands, Inc. Menaik Bercampur

AISkor Stockmoo

0.5
Konsensus Penganalisis 2.0
Aktiviti Orang Dalam NA
Volatiliti Harga 3.0
Purata Bergerak Teknikal -2.5
Osilator Teknikal -0.5
Purata 0.50

Saham Serupa

Stok Modal Pasaran DY P/E (TTM) P/B
TLRY 1 B - - 0.610
RGC 6 B - - 1.22
ANIP 2 B - 53.03 3.75
COLL 2 B - 29.36 5.37
AMPH 1 B - 12.26 1.62
DVAX 1 B - - 2.41

Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure consists of CBD products and alcohol.

Sektor Healthcare
Industri Drug Manufacturers - Specialty & Generic
Gaya Pelaburan Small Value
% Dimiliki oleh Orang Dalam 0.69%
% Dimiliki oleh Institusi 10.10%

Tiada data dalam julat masa ini.

Tiada data dalam julat masa ini.

Tarikh Jenis Butiran
04 Dec 2025 Pengumuman Tilray Releases the Ultimate 2025 Holiday Drink Gift Guide, Celebrating Seasonal Sips and Moments of Connection from Coast to Coast
04 Dec 2025 Pengumuman 2025 Cannabis Holiday Gift Guide Highlights Canada’s Most Popular Cannabis Products for the Holiday Season
26 Nov 2025 Pengumuman Tilray Brands Announces Implementation of Previously Approved 1-for-10 Reverse Stock Split
24 Nov 2025 Pengumuman Tilray Unveils Good Supply Vapes in Québec Following the Recent Introduction of Vape Products in Québec
17 Nov 2025 Pengumuman Tilray Brands Publishes New Investor Presentation Highlighting Leadership Across Beverage, Cannabis and Wellness Industries, Showcasing Its Global Growth Strategy and Transformation into a Diversified CPG Powerhouse Shaping the Future of Consumer Products
13 Nov 2025 Pengumuman 10 Barrel Pub Beer Taps Big Buck Hunter for Epic Cheap Fun Hunting SZN – Limited Edition Cans, Dive Bar Prizes, and $10,000 Arcade Giveaway Ignite Pacific Northwest
11 Nov 2025 Pengumuman Tilray Brands Condemns Misguided Prohibitionist Measures and Champions Responsible Hemp Regulations that Keep Consumers Safe and Businesses Thriving
04 Nov 2025 Pengumuman Tilray Medical Sets the Standard for Compassionate Pricing, Broadening Access to Medical Cannabis for Patients, Seniors, First Responders, and Veterans Through Expanded Pricing Programs Across Canada
01 Nov 2025 CNBC 'Trump effect' raises hopes for cannabis rally as investors bet on federal reforms, softer marijuana stance
30 Oct 2025 Pengumuman Tilray Brands Sets Sights on Asia: Bringing Award-Winning Craft Beers to Japan’s Premier American Craft Beer Experience Festival
23 Oct 2025 Pengumuman Redhook Brewing Launches Redhook 81, Celebrating Pacific Northwest Roots and the Spirit of Hard Work
17 Oct 2025 Pengumuman Tilray Brands Marks Seven Years of Cannabis Legalization in Canada with the #1 Market-Leading Position by Revenue and Pioneering Brands with Growing Market Share in the World’s Largest Federally Legal Cannabis Market
13 Oct 2025 Pengumuman Tilray Medical Announces Expansion Plans in Panama, Strengthening Global Cannabis Leadership and Accelerating International Growth
09 Oct 2025 Pengumuman Tilray Brands Reports Strong First Quarter Fiscal 2026 Results, Highlighting Continued Growth with Record Q1 Net Revenue of $210 Million and Net Income
09 Oct 2025 Pengumuman Tilray Brands Reports Strong First Quarter Fiscal 2026 Results, Highlighting Continued Growth with Record Q1 Net Revenue of $210 Million and Net Income
30 Sep 2025 Pengumuman Tilray, a Global Leader in Medical Cannabis, Announces Expansion of Premium Craft Cannabis Production at its Advanced EU-GMP Facility in Germany; Tilray Medical Enhances Tilray Craft Cannabis Portfolio with New Patient-Centered Offerings
30 Sep 2025 Pengumuman Tilray, a Global Leader in Medical Cannabis, Announces Expansion of Premium Craft Cannabis Production at its Advanced EU-GMP Facility in Germany; Tilray Medical Enhances Tilray Craft Cannabis Portfolio with New Patient-Centered Offerings
25 Sep 2025 Pengumuman Tilray Brands, Inc. to Announce First Quarter Fiscal Year 2026 Financial Results on October 9, 2025
23 Sep 2025 Pengumuman Tilray Beverages Unveils New Fall Seasonal Craft Brews with Oktoberfest-Inspired Lineup
17 Sep 2025 Pengumuman Broken Coast Cannabis Brand Launches Premium and Limited BC Selects Line and Unveils New Strain “Sprits 26”, Elevates Craft Portfolio with Modern Blue Dream Release
16 Sep 2025 Pengumuman Hop Valley Brewing and Oregon Athletics Announce the Launch of Dang Green IPA, the First Official Craft Beer for the Oregon Ducks
09 Sep 2025 Pengumuman Breckenridge Brewery Awarded Silver Certification by the Colorado Green Business Network for Excellence in Sustainability Practices
Papar semua

Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.

Portfolio

AI Templat

Peringatan harga anda

Profil Risiko

| | | | |
Konservatif
Sederhana Konservatif
Sederhana
Sederhana Agresif
Agresif
Margin Keselamatan (EP)
Keuntungan Separa (TP1)
Keuntungan Sasaran (TP2)
Kerugian Maksimum (SL)

Penafian: Perkara di atas adalah untuk tujuan ilustrasi sahaja dan BUKAN nasihat pelaburan. Dapatkan nasihat daripada penasihat kewangan yang berkelayakan.

Harga Masuk (EP)

Ambil Untung 1 (TP1)

Ambil Untung 2 (TP2)

Henti Rugi (SL)

Julat 52 Minggu
 
52WL
 
52WH
SL
EP
TP1
TP2

Semua harga peringatan berada dalam julat harga 52 minggu

Keuntungan Nyata -
Keuntungan Tidak Nyata -
Dividen Diterima 2025 -
Jumlah Untung -
Pulangan Purata -
Kuantiti (Beli) -
Purata Harga (Beli) -
Kuantiti (Jual) -
Purata Harga (Jual) -
Tiada saham yang memenuhi kriteria anda